Bayer’s sevabertinib picks up a second-line indication for HER2-mutated disease, joining Boehringer’s zongertinib on the US ...
The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).
Approximately 20% of new lung cancer diagnoses occur in nonsmokers in the U.S., according to The Ohio State University ...
With 18.7% of eligible adults reporting being up to date on lung cancer screening in a national survey, this was estimated to ...
New research is raising concerns this Lung Cancer Awareness Month, showing an increase in lung cancer diagnoses among younger ...
A new report says too few eligible Americans are being checked for the country’s deadliest cancer before it spreads.
The pro wrestling world has been sending love and prayers to AEW women’s wrestler Rebel after she announced on Sunday that ...
Dr Jilly O'Hagan says she is "hugely concerned" after three patients in her surgery received a late cancer diagnosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback